Home Russia’s Covid vaccine faces global production hurdles
Russia’s Covid vaccine faces global production hurdles
Moscow has entrusted future of Sputnik V jab to sprawling network of private companies around world
World Economy News
17 Feb 2021 • 5 min read
A global network of private factories that Russia is relying on to supply its Sputnik V coronavirus vaccine to international markets is months away from reaching full production levels, raising doubts over Moscow’s ability to honour dozens of agreements with foreign countries.
The Kremlin funded the development of Sputnik V but lacks the production capacity to make enough of it, meaning Russia must now depend on factories in Brazil, India and South Korea if it is going to meet a target of vaccinating almost one-tenth of the world’s population.